TY - JOUR
T1 - Diabetic nephropathy
T2 - A national dialogue
AU - Breyer, Matthew D.
AU - Coffman, Thomas M.
AU - Flessner, Michael F.
AU - Fried, Linda F.
AU - Harris, Raymond C.
AU - Ketchum, Christian J.
AU - Kretzler, Matthias
AU - Nelson, Robert G.
AU - Sedor, John R.
AU - Susztak, Katalin
PY - 2013
Y1 - 2013
N2 - The National Institute of Diabetes and Digestive and Kidney Diseases-supported Kidney Research National Dialogue (KRND) asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. Several high-priority objectives for diabetic nephropathy were identified in data and sample collection, hypothesis generation, hypothesis testing, and translation promotion. The lack of readily available human samples linked to comprehensive phenotypic, clinical, and demographic data remains a significant obstacle. With data and biological samples in place, several possibilities exist for using new technologies to develop hypotheses. Testing novel disease mechanisms with state- of-the-art tools should continue to be the foundation of the investigative community. Research must be translated to improve diagnosis and treatment of people. The objectives identified by the KRND provide the research community with future opportunities for improving the prevention, diagnosis, and treatment of diabetic nephropathy.
AB - The National Institute of Diabetes and Digestive and Kidney Diseases-supported Kidney Research National Dialogue (KRND) asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. Several high-priority objectives for diabetic nephropathy were identified in data and sample collection, hypothesis generation, hypothesis testing, and translation promotion. The lack of readily available human samples linked to comprehensive phenotypic, clinical, and demographic data remains a significant obstacle. With data and biological samples in place, several possibilities exist for using new technologies to develop hypotheses. Testing novel disease mechanisms with state- of-the-art tools should continue to be the foundation of the investigative community. Research must be translated to improve diagnosis and treatment of people. The objectives identified by the KRND provide the research community with future opportunities for improving the prevention, diagnosis, and treatment of diabetic nephropathy.
UR - http://www.scopus.com/inward/record.url?scp=84883685746&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883685746&partnerID=8YFLogxK
U2 - 10.2215/CJN.03640413
DO - 10.2215/CJN.03640413
M3 - Article
C2 - 23788618
AN - SCOPUS:84883685746
SN - 1555-9041
VL - 8
SP - 1603
EP - 1605
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 9
ER -